Doppl Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

Doppl General Information

Description

Developer of biological modeling systems designed for medical research and therapeutic development. The company offers uses organoid and organ-on-chip models with applications in oncology, inflammatory and rare diseases, and immuno-oncology, while also supporting compound profiling, epithelial fluid transport studies, and tailored model development for specific tissues or disease states, enabling pharmaceutical and biotechnology markets to assess drug safety, study disease mechanisms, and advance personalized medicine approaches with higher predictive accuracy than traditional methods.

Contact Information

Website
www.doppl.ch
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • EPFL Innovation Building L
  • 1015 Lausanne
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • EPFL Innovation Building L
  • 1015 Lausanne
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Doppl Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 11-Nov-2025 Completed Generating Revenue
4. Debt - General 21-Sep-2022 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Spin-Off Completed Generating Revenue
To view Doppl’s complete valuation and funding history, request access »

Doppl Patents

Doppl Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12674124-B2 Well for cultivating biological material Active 30-May-2018
US-20210301237-A1 Well for cultivating biological material Active 30-May-2018

Doppl Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Doppl Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
EPFL Innovation Park Accelerator/Incubator
Ecole Polytechnique Federale de Lausanne University
SUN bioscience Corporation
To view Doppl’s complete investors history, request access »

Doppl FAQs

  • When was Doppl founded?

    Doppl was founded in 2022.

  • Where is Doppl headquartered?

    Doppl is headquartered in Lausanne, Switzerland.

  • What is the size of Doppl?

    Doppl has 14 total employees.

  • What industry is Doppl in?

    Doppl’s primary industry is Drug Discovery.

  • Is Doppl a private or public company?

    Doppl is a Private company.

  • What is Doppl’s current revenue?

    The current revenue for Doppl is .

  • How much funding has Doppl raised over time?

    Doppl has raised $103K.

  • Who are Doppl’s investors?

    EPFL Innovation Park, Ecole Polytechnique Federale de Lausanne, and SUN bioscience have invested in Doppl.

  • When was Doppl acquired?

    Doppl was acquired on 11-Nov-2025.

  • Who acquired Doppl?

    Doppl was acquired by InSphero.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process